These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24431079)

  • 1. Dietary flavonoids modulate CYP2C to improve drug oral bioavailability and their qualitative/quantitative structure-activity relationship.
    Wang HJ; Pao LH; Hsiong CH; Shih TY; Lee MS; Hu OY
    AAPS J; 2014 Mar; 16(2):258-68. PubMed ID: 24431079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of interaction between fluvastatin and oral hypoglycemic agents in healthy subjects and in patients with non-insulin-dependent diabetes mellitus.
    Appel S; Rüfenacht T; Kalafsky G; Tetzloff W; Kallay Z; Hitzenberger G; Kutz K
    Am J Cardiol; 1995 Jul; 76(2):29A-32A. PubMed ID: 7604792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the in vitro metabolism data for predicting the clearance and drug-drug interaction potential of CYP2C9 substrates.
    Andersson TB; Bredberg E; Ericsson H; Sjöberg H
    Drug Metab Dispos; 2004 Jul; 32(7):715-21. PubMed ID: 15205386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Bu-Zhong-Yi-Qi-Tang on hepatic drug-metabolizing enzymes and plasma tolbutamide concentration in rats.
    Yao HT; Chang YW; Uramaru N; Watanabe Y; Kitamura S; Kuo YH; Lii CK; Yeh TK
    J Ethnopharmacol; 2012 Jun; 142(1):121-8. PubMed ID: 22564357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of dietary flavonoids on purified hepatic NADH-cytochrome b5 reductase: structure-activity relationships.
    Çelik H; Koşar M
    Chem Biol Interact; 2012 May; 197(2-3):103-9. PubMed ID: 22542668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytochrome P-450 activity in rat liver microsomes by the naturally occurring flavonoid, quercetin.
    Sousa RL; Marletta MA
    Arch Biochem Biophys; 1985 Jul; 240(1):345-57. PubMed ID: 3925883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional status affects fluvastatin-induced hepatotoxicity and myopathy in rats.
    Sugatani J; Sadamitsu S; Kurosawa M; Ikushiro S; Sakaki T; Ikari A; Miwa M
    Drug Metab Dispos; 2010 Oct; 38(10):1655-64. PubMed ID: 20587623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
    Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of the flavonol quercetin in neonatal calves after oral administration of quercetin aglycone or rutin.
    Maciej J; Schäff CT; Kanitz E; Tuchscherer A; Bruckmaier RM; Wolffram S; Hammon HM
    J Dairy Sci; 2015 Jun; 98(6):3906-17. PubMed ID: 25795488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysaccharide peptides from COV-1 strain of Coriolus versicolor inhibit tolbutamide 4-hydroxylation in the rat in vitro and in vivo.
    Yeung JH; Chan SL; Or PM
    Food Chem Toxicol; 2006 Aug; 44(8):1414-23. PubMed ID: 16698161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of fluvastatin.
    Scripture CD; Pieper JA
    Clin Pharmacokinet; 2001; 40(4):263-81. PubMed ID: 11368292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of different CYP enzymes in the formation of specific fluvastatin metabolites by human liver microsomes.
    Toda T; Eliasson E; Ask B; Inotsume N; Rane A
    Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):327-32. PubMed ID: 19663817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin: effect on human cytochrome P-450 and implications for metabolic drug interactions.
    Fischer V; Johanson L; Heitz F; Tullman R; Graham E; Baldeck JP; Robinson WT
    Drug Metab Dispos; 1999 Mar; 27(3):410-6. PubMed ID: 10064574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo inhibition profile of cytochrome P450TB (CYP2C9) by (+/-)-fluvastatin.
    Transon C; Leemann T; Vogt N; Dayer P
    Clin Pharmacol Ther; 1995 Oct; 58(4):412-7. PubMed ID: 7586933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro biotransformation of flavonoids by rat liver microsomes.
    Nielsen SE; Breinholt V; Justesen U; Cornett C; Dragsted LO
    Xenobiotica; 1998 Apr; 28(4):389-401. PubMed ID: 9604302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA; Tjia JF; Back DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic interactions of magnolol with cytochrome P450 enzymes: uncompetitive inhibition of CYP1A and competitive inhibition of CYP2C.
    Kim SB; Kang HE; Cho HJ; Kim YS; Chung SJ; Yoon IS; Kim DD
    Drug Dev Ind Pharm; 2016; 42(2):263-9. PubMed ID: 26133083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids.
    Breinholt VM; Offord EA; Brouwer C; Nielsen SE; Brøsen K; Friedberg T
    Food Chem Toxicol; 2002 May; 40(5):609-16. PubMed ID: 11955666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors.
    Transon C; Leemann T; Dayer P
    Eur J Clin Pharmacol; 1996; 50(3):209-15. PubMed ID: 8737761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of chrysosplenetin on the pharmacokinetics and anti-malarial efficacy of artemisinin against Plasmodium berghei as well as in vitro CYP450 enzymatic activities in rat liver microsome.
    Wei S; Ji H; Yang B; Ma L; Bei Z; Li X; Dang H; Yang X; Liu C; Wu X; Chen J
    Malar J; 2015 Nov; 14():432. PubMed ID: 26537009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.